细胞外囊泡在动脉样硬化心血管疾病:新兴的角色和机制
Haoxuan Deng1, Wei Qiu1, Yunyan Zhang1
1Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in cardiovascular medicine
|July 9, 2025
概括
细胞外囊泡 (EVs) 是动脉样硬化心血管疾病的关键参与者,影响炎症和脂质代谢. 本综述探讨了它们的诊断和治疗潜力,尽管目前临床应用面临挑战.
科学领域:
- 心血管生物学 心血管生物学
- 细胞和分子医学是细胞和分子医学.
- 生物医学工程 生物医学工程
背景情况:
- 动脉样硬化心血管疾病的发病过程涉及复杂的细胞相互作用.
- 细胞外囊泡 (EVs) 正在成为心血管疾病进展的关键调解者.
- 在动脉样硬化 (AS) 中,EVs会影响炎症,细胞间通信和脂质代谢.
研究的目的:
- 提供对电动汽车在AS中的作用的全面概述.
- 突出了EV在AS的诊断和治疗应用中的最新进展.
- 确定挑战,并告知EVs在心血管疾病中的未来临床应用.
主要方法:
- 关于动脉样硬化中EVs的当前研究的文献综述.
- 对EVs影响AS进展和斑块稳定的机制的分析.
- 评估最近基于电动汽车的诊断和治疗方面的进展.
主要成果:
- 通过调节炎症反应和脂质代谢,EVs显著促进AS的发病.
- EVs在AS中起着双重作用,影响疾病进展和斑块稳定性.
- 目前的研究强调了电动汽车作为生物标志物和药物输送工具的潜力.
结论:
- 电动汽车在心血管疾病的发病过程中至关重要,并且对临床应用具有前景.
- 克服EV分离,净化和临床试验数据的挑战对于治疗转化至关重要.
- 需要进一步的研究才能充分实现EVs在治疗动脉样硬化心血管疾病方面的诊断和治疗潜力.
相关概念视频
Atherosclerosis I: Introduction
92
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92
Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Coronary Artery Disease I: Introduction
63
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
63
Lipid-derived Compounds in the Human Body
5.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.4K
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41


